Western Pacific Region Index Medicus

Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients: The younger, the better.

Author: Lan ZHU ¹ ; Lei ZHANG ² ; Wenjun SHANG ³ ; Wenhua LIU ⁴ ; Rula SA ¹ ; Zhiliang GUO ¹ ; Longshan LIU ⁵ ; Jinghong TAN ⁵ ; Hengxi ZHANG ⁵ ; Yonghua FENG ³ ; Wenyu ZHAO ² ; Wenqi CONG ⁶ ; Jianyong WU ⁶ ; Changxi WANG ⁵ ; Gang CHEN ¹
Author Information

1. Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, Hubei 430030, China.
2. Department of Organ Transplantation, First Affiliated Hospital, Naval Medical University, Shanghai 200443, China.
3. Department of Renal Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, China.
4. Clinical Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
5. Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China.
6. Center of Nephrology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China.
Publication Type:Journal Article
From: Chinese Medical Journal 2025;138(2):225-227
CountryChina
Language:English